IndraLab

Statements


| 1

reach
"Acrolein inhibited NF-kappaB and IRF3 activation by LPS, but it did not inhibit NF-kappaB or IRF3 activation by MyD88, inhibitor kappaB kinase (IKK) beta, TRIF, or TNF-receptor-associated factor family member associated NF-kappaB activator (TANK)-binding kinase 1 (TBK1)."